Tag: BLUE

Navigating Uncertainty: Analyst Ratings and Price Targets for &Bluebird bio, Inc.

by Elaine Mendonça

July 17, 2023

&Bluebird bio, Inc.: Analyst Ratings and Price Targets Reflect Investor Uncertainty in a Dynamic Biotech Landscape Publication Date: July 16, ...

Credit Suisse AG Increases Holdings in bluebird bio, Inc. following Impressive Earnings Report

by Roberto Liccardo

June 13, 2023

As of June 11, 2023, Credit Suisse AG has reported an increase in its holdings in bluebird bio, Inc. by ...

Mitsubishi UFJ Kokusai Asset Management Diversifies Portfolio with Bluebird Bio Investment: An Exciting Opportunity for Innovation in Gene Therapy

by Elaine Mendonça

May 11, 2023

In a recent disclosure to the Securities and Exchange Commission, Mitsubishi UFJ Kokusai Asset Management Co. Ltd reported that it ...

About Us

Our team of experienced journalists and industry experts is committed to providing you with the latest and most accurate information on a wide range of topics, from finance and technology to politics and the economy.

We are proud to be part of the Best Stocks team and to offer our readers exceptional content that is informed by our combined expertise. We look forward to continuing to serve our readers and to playing a key role in the world of business analysis and reporting.

No Result

View All Result

Tag: BLUE

Navigating Uncertainty: Analyst Ratings and Price Targets for &Bluebird bio, Inc.

Credit Suisse AG Increases Holdings in bluebird bio, Inc. following Impressive Earnings Report

Mitsubishi UFJ Kokusai Asset Management Diversifies Portfolio with Bluebird Bio Investment: An Exciting Opportunity for Innovation in Gene Therapy

Recent Posts

Categories

About Us